Prophylaxis against middle ear barotrauma in US hyperbaric oxygen therapy centers. | Canada Hyperbarics Skip to main content
Clinical Study The American journal of emergency medicine 1996

Prophylaxis against middle ear barotrauma in US hyperbaric oxygen therapy centers.

Capes JP, Tomaszewski C — The American journal of emergency medicine, 1996

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a phone survey of hospital-based hyperbaric oxygen therapy centers in the United States to assess their routine practices for preventing middle ear barotrauma.

What They Found

More than a fifth of centers (30 of 126) always performed prophylactic myringotomies on intubated patients, and 19 of 86 centers did so for infants. A third of centers (49 of 145) routinely administered prophylactic drugs, with topical nasal decongestants preferred over systemic medications. These findings revealed significant variance in clinical practice among US centers, with many using unproven therapies.

What This Means for Canadian Patients

While this study focused on US practices, it highlights the importance of developing standardized, evidence-based protocols for preventing middle ear barotrauma during hyperbaric oxygen therapy. Canadian patients could benefit from clear guidelines to ensure consistent and effective care, reducing risks like permanent hearing loss.

Canadian Relevance

This study has no direct Canadian connection as it exclusively surveyed hyperbaric oxygen therapy centers within the United States.

Study Limitations

The study's primary limitation is its descriptive nature, surveying current practices without evaluating the efficacy or outcomes of the various prophylactic methods.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 8906761
Year Published 1996
Journal The American journal of emergency medicine
MeSH Terms Adult; Barotrauma; Data Collection; Ear, Middle; Humans; Infant; Nasal Decongestants; Oxygen Inhalation Therapy; Tympanic Membrane; United States

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.